Showing results (1-10 of 459) with videos related to
Sort By:
Pageof 46
Hematology. American Society of Hematology. Education Program|December 7, 2024
Relapsed/refractory CLL: the role of allo-SCT, CAR-T, and T-cell engagersArnon P Kater, Tanya SiddiqiClinical Lymphoma, Myeloma & Leukemia|June 10, 2010
Standards for the treatment of relapsed chronic lymphocytic leukemia: a case-based studyArnon P Kater, Sanne H ToninoBest Practice & Research. Clinical Haematology|October 16, 2016
TP53 dysfunction in CLL: Implications for prognosis and treatmentGera D Te Raa, Arnon P KaterBlood Advances|February 9, 2021
Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19Chaja F Jacobs, Eric Eldering, Arnon P KaterFrontiers in Oncology|November 2, 2020
Proliferative Signals in Chronic Lymphocytic Leukemia; What Are We Missing?Marco V Haselager, Arnon P Kater, Eric ElderingHaematologica|August 5, 2017
Chronic lymphocytic leukemia cells are active participants in microenvironmental cross-talkMartijn Ha van Attekum, Eric Eldering, Arnon P KaterChest|November 14, 2006
Thymosin beta4 sequesters actin in cystic fibrosis sputum and decreases sputum cohesivity in vitroBruce K Rubin, Arnon P Kater, Allan L GoldsteinLeukemia|June 20, 2022
Tipping the balance: toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphomaYvonne J Thus, Eric Eldering, Arnon P Kater, et al.International Journal of Molecular Sciences|September 6, 2019
Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic LeukemiaTom Hofland, Eric Eldering, Arnon P Kater, et al.Pageof 46